Vivacelle Bio Enrolls First Patient in Phase 3 Trial of Hypovolemia Due to Septic Shock for Phospholipid Nanoparticle-Based VBI-S https://t.co/MecNC1pJD1
Photo of most who are working in my laboratory - “Laboratory for the Study of Shock and Reanimation” (and all good ideas) . Left to right
Kennedy Chow, Gelilla Daniel, Nathan Carpenter, Cuthbert Simpkins, Prashanth Anamthathmakula, Philemon Shallie, Megan Angell
This is a press release on the beginning of of our phase three and hopefully final trial before taking VBI-S to market for patients with septic shock.
https://t.co/nhzd9icGIS
Vivacelle Bio’s President and Chief Innovation Officer to Present Data Highlighting the Company’s Late Stage Clinical Programs at the Bio International Convention 2024
https://t.co/9VAPMMyZxm
Dr. CO Simpkins on Dr. King's Speech at Galilee taped https://t.co/N1qXm7OC9c - Google Drive My father Dr. CO Simpkins on the building of Galilee Baptist Church in Shreveport Louisiana by former slaves and the speech given by MLK there when he was 93 yo. https://t.co/mwHCdNiDcg
My wife Diane me and Dr. William Sweatt at the annual MLK celebration in Lake Jackson Tx last month. My keynote address was “ My Pathway From Segregation to Science.
The NIH chose our biotech company Vivacelle Bio to be a “Showcase” company at the Bio International Convention in June. This is a surprise and an honor!!! Selection was based on our development of non antibiotic treatments of lethal infection to counteract antibiotic resistance
Our laboratory continues to push the line between life and death farther back. We have brought rats back to life after death due to blood loss. Our goal is to extend this to humans. We explore death to better understand life.